首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of The American Academy Of Dermatology

Journal Of The American Academy Of Dermatology杂志,由Mosby Inc.出版,于1979年创刊,Monthly,出版语言English,ISSN:0190-9622,E-ISSN:1097-6787。

投稿咨询
Journal Of The American Academy Of Dermatology
Journal Of The American Academy Of Dermatology
Journal Of The American Academy Of Dermatology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
12.3
CiteScore
6.1
期刊收录
SCI、SCIE

Journal Of The American Academy Of Dermatology(中文译名:《美国皮肤病学会杂志》),ISSN:0190-9622,EISSN:1097-6787,是Mosby Inc.出版的国际性学术期刊,创刊于1979年,以Monthly形式稳定发行,2026年总发文量约215篇。该刊采用非OA开放访问,学科归属为医学 - 皮肤病学。该刊是医学、皮肤病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达12.3,2025年期刊CiteScore为6.1,2025年期刊自引率约6.5%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Journal Of The American Academy Of Dermatology长期聚焦医学、皮肤病学及相关产业的技术应用前沿,平均审稿周期一般,3-6周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、皮肤病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACanada、Spain、France、GERMANY (FED REP GER)、England、South Korea等为核心发文国家与地区;HARVARD UNIVERSITYUNIVERSITY OF CALIFORNIA SYSTEM、NORTHWESTERN UNIVERSITY、UNIVERSITY OF TEXAS SYSTEM、UNIVERSITY OF PENNSYLVANIA、ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI、BRIGHAM & WOMEN'S HOSPITAL等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
DERMATOLOGY 皮肤病学
1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
DERMATOLOGY 皮肤病学
1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
DERMATOLOGY 皮肤病学
1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:DERMATOLOGY SCIE Q1 1 / 99

99.5

学科:DERMATOLOGY SCIE Q1 3 / 99

97.47

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:DERMATOLOGY SCIE Q1 1 / 96

99.5

学科:DERMATOLOGY SCIE Q1 2 / 96

98.44


中国学者近期发文

1
KLRB1 and IL12RB1 are pretherapeutic predictors of time to relapse in patients with psoriasis treated with IL-17 blockad

Author:Wang, Hailun; Zhang, Li; Xu, Xintian; Le, Yunchen; Cao, Han; Quan, Cheng; Xue, Feng; Hao, Pei; Pan, Meng; Li, Xia; Zheng, Jie; Chen, Lihong

Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. 1158-1166. DOI: 10.1016/j.jaad.2025.11.081

2
Characterization and treatment outcomes of rituximab therapy in super-responders and rituximab-refractory pemphigus patients: A single-center retrospective stud

Author:Wu, Zhili; Jiang, Jiefeng; Duan, Keyun; Li, Guomin; Guo, Feng; Zhang, Jiao; Xue, Ruzeng

Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. 1177-1183. DOI: 10.1016/j.jaad.2025.12.030

3
Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective stud

Author:Huang, Jundong; Jian, Jia; Li, Min; Ji, Ruxin; Tian, Tian; Liang, Xiaobing; Zhao, Zhixiang; Tang, Yan; Li, Ji; Liu, Fangfen; Shi, Wei

Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. 1144-1150. DOI: 10.1016/j.jaad.2025.12.020

4
Advances and challenges in diagnostic strategies for HLRCC-A Letter to the Editor regarding the study by Ouchene et al on HLRC

Author:Zheng, Zunwen; Xie, Deqian; Lin, Yiling; Wu, Guangzhen

Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. e257-e259. DOI: 10.1016/j.jaad.2025.09.114

5
Comment on Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patient

Author:Yao, Guotai; Wang, Zhongzhi

Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. e277-e277. DOI: 10.1016/j.jaad.2025.09.116

6
Artificial intelligence in dermatology: Ethical considerations from model selection to public administratio

Author:Yang, Xing-Yu; Chen, Mo

Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. e301-e302. DOI: 10.1016/j.jaad.2025.10.167

7
Association of primary tumor location with all-cause and cancer-specific mortality in cutaneous malignant melanoma patient

Author:Wei, Shiyuan; Su, Licong; Wu, Liangzhi

Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. 1116-1125. DOI: 10.1016/j.jaad.2025.11.027

8
Comments on Long-term, real-world effectiveness of adalimumab in the treatment of hidradenitis suppurativ

Author:Long, Qing; Li, Yan

Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. e295-e296. DOI: 10.1016/j.jaad.2025.10.164

9
Letter to the editor: Radiologic imaging aids management of high-risk cutaneous squamous cell carcinoma: A retrospective cohort stud

Author:Liu, Dequan; Che, Xiangyu; Wu, Guangzhen

Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. e275-e276. DOI: 10.1016/j.jaad.2025.09.115

10
Disproportionality analysis of dermatologic adverse events associated with nirogacestat: Insights from the US Food and Drug Administration Adverse Event Reporting Syste

Author:Ke, Jianhao; Deng, Hui; Mao, Hongfeng

Journal: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; Vol. 94, Issue 4, pp. e299-e300. DOI: 10.1016/j.jaad.2025.10.166


在线咨询

Journal Of The American Academy Of Dermatology

国际简称:J AM ACAD DERMATOL参考译名:美国皮肤病学会杂志

年发文量:215 CiteScore:6.1 是否预警:否 Gold OA文章占比:21.05% 研究类文章占比:93.02%

杂志社联系方式:MOSBY-ELSEVIER, 360 PARK AVENUE SOUTH, NEW YORK, USA, NY, 10010-1710

Journal Of The American Academy Of Dermatology